AngioDynamics Inc (ANGO)
6.31
+0.04
(+0.64%)
USD |
NASDAQ |
May 31, 16:00
6.305
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Research and Development Expense (TTM): 32.65M for Feb. 29, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| February 29, 2024 | 32.65M |
| November 30, 2023 | 31.31M |
| August 31, 2023 | 29.49M |
| May 31, 2023 | 29.88M |
| February 28, 2023 | 29.89M |
| November 30, 2022 | 30.32M |
| August 31, 2022 | 31.68M |
| May 31, 2022 | 30.74M |
| February 28, 2022 | 31.98M |
| November 30, 2021 | 33.26M |
| August 31, 2021 | 34.78M |
| May 31, 2021 | 36.39M |
| February 28, 2021 | 34.52M |
| November 30, 2020 | 34.35M |
| August 31, 2020 | 32.40M |
| May 31, 2020 | 29.68M |
| February 29, 2020 | 29.34M |
| November 30, 2019 | 27.86M |
| August 31, 2019 | 27.18M |
| May 31, 2019 | 28.26M |
| February 28, 2019 | 26.70M |
| November 30, 2018 | 26.24M |
| August 31, 2018 | 25.27M |
| May 31, 2018 | 24.34M |
| February 28, 2018 | 24.58M |
| Date | Value |
|---|---|
| November 30, 2017 | 24.07M |
| August 31, 2017 | 23.88M |
| May 31, 2017 | 24.15M |
| February 28, 2017 | 25.51M |
| November 30, 2016 | 25.37M |
| August 31, 2016 | 25.63M |
| May 31, 2016 | 25.05M |
| February 29, 2016 | 25.07M |
| November 30, 2015 | 26.12M |
| August 31, 2015 | 26.00M |
| May 31, 2015 | 26.59M |
| February 28, 2015 | 27.01M |
| November 30, 2014 | 27.20M |
| August 31, 2014 | 28.13M |
| May 31, 2014 | 28.12M |
| February 28, 2014 | 27.20M |
| November 30, 2013 | 25.94M |
| August 31, 2013 | 25.95M |
| May 31, 2013 | 26.32M |
| February 28, 2013 | 25.10M |
| November 30, 2012 | 23.88M |
| August 31, 2012 | 22.00M |
| May 31, 2012 | 20.51M |
| February 29, 2012 | 20.84M |
| November 30, 2011 | 21.59M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
27.18M
Minimum
Aug 2019
36.39M
Maximum
May 2021
31.46M
Average
31.31M
Median
Nov 2023
Research and Development Expense (TTM) Benchmarks
| Becton Dickinson & Co | 1.176B |
| Outset Medical Inc | 56.15M |
| Boston Scientific Corp | 1.444B |
| Perspective Therapeutics Inc | 24.91M |
| Xtant Medical Holdings Inc | 1.689M |